Author Affiliation: United States Senate Committee on Health, Education, Labor, and Pensions, Subcommittee on Public Health, Washington, DC.
Fueled by rapidly increasing government funding, the pace of biomedical
research has soared during the past decade. When I first entered medical school
3 decades ago, coronary artery bypass surgery was still in its infancy. Rapid
improvements in pacemaker technology were being made, and noninvasive procedures
to treat coronary disease were just beginning to be investigated. Today, applications
of novel therapies and noninvasive procedures such as thrombolytic agents
and percutaneous angioplasty are routine, pharmacologic agents such as calcium
channel blockers and statins have been used for 20 years, and improved diagnostic
tests such as single-photon emission computed tomography are widely used.
Frist WH. Federal Funding for Biomedical ResearchCommitment and Benefits. JAMA. 2002;287(13):1722-1724. doi:10.1001/jama.287.13.1722